August 2012 - Page 9 of 17

FridayAug 17, 2012 3:07 pm

International Stem Cell Corp. (ISCO) Highlighted by Seeking Alpha Article as Biotech with Strong Lead in Regenerative Stem Cell Therapy for Parkinson’s

International Stem Cell was listed first among emerging biotech alternatives in an article over at Seeking Alpha that showcased stem cell technology and other improved solutions to the largely ineffective 'band-aid' drug-based offerings currently out there for treating Parkinson's. The devastating degenerative neurological disease is now estimated to be affecting a staggering 1M Americans alone (7-10M globally), with another 60k domestic cases diagnosed every year. ISCO is on the cutting-edge of stem cell therapeutics development, with a rich portfolio of regenerative medicine technologies. The company's recent (July 18) disclosure that they will be taking the Parkinson’s Disease Program to the…

FridayAug 17, 2012 2:19 pm

Longhai Steel, Inc. (LGHS) is “One to Watch”

Longhai Steel is a leading producer of high-quality steel wire in eastern China, with annual capacity of 1.5 million metric tons. Longhai's wire is manufactured into screws, nails, and wire mesh used for fencing and to reinforce concrete. Longhai recently expanded its production facility to include specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Longhai Steel is headquartered in Xingtai, Hebei province, the People's Republic of China. The company's competitive advantages are its advanced production equipment and process technology, high product quality, expedited production, and close proximity to distributors and end…

FridayAug 17, 2012 12:27 pm

USA Recycling Industries, Inc. (USRI) Sees Used Tires and Other Scrap Material as a Mission

With what is estimated to be well over 200 million vehicles on the road in the U.S. alone, one can imagine the volume of tires being replaced on an annual basis. Hundreds of millions of tires are scrapped every year in the U.S., and, in spite of private and governmental efforts, millions of them still end up in landfills. And that’s a problem, because tires are designed to be tough and long lasting, not easily broken down, plus they capture empty space, increasing their discard volume. It’s a special tragedy, since tires can now be recycled into many things, including…

FridayAug 17, 2012 10:54 am

Teletouch Communications, Inc. (TLLE) Sells Two-Way Radio Business, Focuses on Broader Cellular and Electronics Distribution

With its start as a Motorola Service Station in east Texas, Teletouch and its predecessor companies have been known for nearly a half century as providers of two-way radio products and services, eventually including cellular, GPS-telemetry, and wireless messaging, and operating a chain of 11 retail and authorized agent stores in North and Central Texas. Today, with its developing presence as a cellular and electronics wholesale distributor, the company has chosen to divest its two-way radio division. Yesterday, Teletouch announced the sale of its two-way radio and public safety equipment business unit for approximately $1.5 million to DFW Communications, Inc.,…

FridayAug 17, 2012 8:45 am

Arotech Corp. (ARTX) Subsidiary Awarded Contract to Supply National Guard Driving Simulators

FAAC, a subsidiary of Arotech, recently announced that the company has been awarded a $6.1 million contract to supply the Army National Guard with Military Operator Driving Simulators (ODS). Under the terms of the contract, FAAC will supply eight trailer systems to the National Guard. Arotech is focused on developing and manufacturing simulation-based training systems as well as multimedia and interactive digital solutions for use in engineering, use-of-force, and driver training simulations for military, law enforcement, security, municipal, and private industry personnel. The National Guard locations receiving the simulators are Arizona, Indiana, Kansas, Kentucky, Massachusetts, South Dakota, and Nevada. Each…

ThursdayAug 16, 2012 3:42 pm

TG Therapeutics, Inc. (TGTX) and Rhizen Pharmaceuticals Announce Partnership to Co-Develop and Commercialize TGR-1202

TG Therapeutics is a clinical-stage biopharm company whose strategy is to acquire, develop, and commercialize pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. In line with this strategy, TG and Rhizen Pharmaceuticals S A today announced their exclusive global agreement to co-develop and commercialize Rhizen's lead product candidate, TGR-1202. "We are excited to enter into this collaboration with Rhizen Pharmaceuticals, whose innovative pre-clinical development program has yielded an impressive portfolio of PI3K delta inhibitors that we are eager to advance into development," Michael S. Weiss, executive chairman and Interim CEO of TG stated in the press…

ThursdayAug 16, 2012 3:21 pm

Silver Bull Resources, Inc. (SVBL) Renews Mitzic License, Reports on Extensive Iron Ore Correlated by Recent Work Program

Silver Bull Resources, the Canadian mineral exploration firm primarily focused on their flagship Sierra Mojada (silver, zinc, and lead) project in Mexico, reported some really good news today out of their 1,243 sq. mile Mitzic site, which is on the western edge of the region’s major iron belt (three deposits greater than 650 metric tonnes at 60% Fe currently under development), in the French-speaking West-Central African democracy of Gabon – as the Gabonese Ministry of Mines renewed the site license for another three years. In addition, the company offered a pertinent status update from the work program conducted on the…

ThursdayAug 16, 2012 2:32 pm

Oncolytics Biotech, Inc. (ONCY) Completes Patient Enrollment in UK Phase I Trial of REOLYSIN

Canadian-based Oncolytics Biotech is focused on the novel approach of developing oncolytic viruses as potential therapeutics for patients afflicted with various types of cancer, including lung, pancreatic, and colorectal cancers. The company's clinical program includes a Phase III trial in head and neck cancer using REOLYSIN, its proprietary formulation of the human reovirus. The company today announced that it has completed its 36 patient enrollment in its U.K. Phase I clinical trial using intravenously-administered REOLYSIN in combination with cyclophosphamide in patients with advanced malignancies. Eligible patients include those who have been diagnosed with advanced or metastatic solid tumors. These include…

ThursdayAug 16, 2012 9:00 am

USA Technologies, Inc. (USAT) Announces Entrance into Mobile Payment Acceptance Market

USA Technologies yesterday introduced ePort Mobile™, an innovative product giving retailers and other merchants the capability of accepting credit and debit cards in a mobile environment through USAT’s highly secure, turnkey ePort Connect® service platform. USAT will leverage its extensive experience, over fifteen years, in transitioning traditionally cash-based, unattended retail businesses to cashless payments to make an efficient, effective entry into the multibillion-dollar mobile payments acceptance market. ePort Mobile will offer: • Three levels of data security – credit card data is encrypted twice and is transmitted using a proprietary communication protocol; • Durable, industrial grade card magnetic swipe reader…

ThursdayAug 16, 2012 8:44 am

World-Renowned Scientists Join International Stem Cell Corp. (ISCO) as Advisors on Parkinson’s Disease Program

Today before the opening bell, International Stem Cell Corp., a California-based biotechnology company focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products, announced that Professor Evan Snyder and Dr. Rosasio Sánchez-Pernaute are now scientific advisors on the company’s Parkinson's disease program. Evan Snyder, MD, PhD is a Professor at the Sanford-Burnham Medical Research Institute and director of Sanford-Burnham's stem cell program and research center. Regarded as one of the pioneers of stem cell research, particularly with regard to regenerative medicine applications, Prof. Snyder is an expert on…

Site Search

Company Search

Month: August 2012